These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21642484)

  • 1. Asenapine for the treatment of stuttering: an analysis of three cases.
    Maguire GA; Franklin DL; Kirsten J
    Am J Psychiatry; 2011 Jun; 168(6):651-2. PubMed ID: 21642484
    [No Abstract]   [Full Text] [Related]  

  • 2. Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.
    Med Lett Drugs Ther; 2010 Feb; 52(1331):9-10. PubMed ID: 20216523
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled trial of asenapine for the prevention of relapse of schizophrenia after long-term treatment.
    Kane JM; Mackle M; Snow-Adami L; Zhao J; Szegedi A; Panagides J
    J Clin Psychiatry; 2011 Mar; 72(3):349-55. PubMed ID: 21367356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naturalistic retrospective review of weight gain in bipolar patients treated with second generation antipsychotics.
    Worthington MA; El-Mallakh RS
    J Clin Psychopharmacol; 2015 Apr; 35(2):192-3. PubMed ID: 25587693
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic reactions and sudden death with asenapine.
    Masters KJ
    J Clin Psychiatry; 2012 May; 73(5):720; author reply 720-1. PubMed ID: 22697198
    [No Abstract]   [Full Text] [Related]  

  • 7. Asenapine: a clinical overview.
    Potkin SG
    J Clin Psychiatry; 2011; 72 Suppl 1():14-8. PubMed ID: 22217438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Asenapine in the Treatment of Bipolar Disorder.
    Vieta E; Montes JM
    Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical pinpoint pupils with asenapine.
    Gill JS; Jambunathan S; Wong S; Wong A
    Asia Pac Psychiatry; 2015 Jun; 7(2):230. PubMed ID: 25923587
    [No Abstract]   [Full Text] [Related]  

  • 10. Asenapine.
    Meltzer HY; Dritselis A; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2009 Nov; 8(11):843-4. PubMed ID: 19876039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs: asenapine, iloperidone, and bepotastine besilate.
    Hussar DA; Abbas CA
    J Am Pharm Assoc (2003); 2010; 50(1):107-10. PubMed ID: 20097650
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and Safety of Asenapine Versus Olanzapine in Combination With Divalproex for Acute Mania: A Randomized Controlled Trial.
    Mahajan V; Arora M; Tandon VR; Gillani Z; Praharaj SK
    J Clin Psychopharmacol; 2019; 39(4):305-311. PubMed ID: 31205195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Nov; 126(3):358-65. PubMed ID: 20537396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the clinical efficacy of asenapine in schizophrenia.
    Minassian A; Young JW
    Expert Opin Pharmacother; 2010 Aug; 11(12):2107-15. PubMed ID: 20642375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asenapine in the treatment of borderline personality disorder: an atypical antipsychotic alternative.
    Martín-Blanco A; Patrizi B; Villalta L; Gasol X; Soler J; Gasol M; Pascual JC
    Int Clin Psychopharmacol; 2014 Mar; 29(2):120-3. PubMed ID: 23962963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia.
    Buchanan RW; Panagides J; Zhao J; Phiri P; den Hollander W; Ha X; Kouassi A; Alphs L; Schooler N; Szegedi A; Cazorla P
    J Clin Psychopharmacol; 2012 Feb; 32(1):36-45. PubMed ID: 22198451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis.
    Berk M; Tiller JW; Zhao J; Yatham LN; Malhi GS; Weiller E
    J Clin Psychiatry; 2015 Jun; 76(6):728-34. PubMed ID: 25612216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes.
    Sawyer L; Azorin JM; Chang S; Rinciog C; Guiraud-Diawara A; Marre C; Hansen K
    J Med Econ; 2014 Jul; 17(7):508-19. PubMed ID: 24720805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
    Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
    J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.